Update on improving tick-borne disease therapy from Dr Petersen.
Update on 9/11 Surveillance Study from Dr Otto.
Update on treatment of B-cell lymphoma from Dr Breen.
Continue reading “Research Update CHF Grant 02317 Update End-Year 3: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma”
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Update on clinical trial for hemangiosarcoma treatment from Dr. Dickerson.
Research Update from Dr. Trepanier looking at environmental chemical exposure and cancer.
Update for research to train pathologists to support Golden Retriever Lifetime Study.
Research update from Dr. Volk on prognostic markers for canine mammary cancer.
Continue reading “Research Update Mid-Year 2 CHF 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes”
FINAL update from Dr. Arenas indicating a potential vaccine for canine brucellosis has been developed and tested in the laboratory on blood samples. The next step to get this vaccine to market would be to test on actual live dogs.
During the initial 1.5 years of this project, we focused our efforts on sample collection across our three target breeds (Standard Poodles, Portuguese Water Dogs, English Cocker Spaniels). We have collected nearly all the required samples from Standard Poodles and Portuguese Water Dogs. Currently, we are focusing our efforts on increasing the number of English Cocker Spaniels we have enrolled in the study. We are also actively recruiting newly diagnosed patients across all three breeds through many online resources.